OHBs, Story

OHB's Margin Story Holds, but the Cash and Bottom-Line Numbers Are Still Playing Catch-Up

Published on 11/14/2026 at 16:53 | Editorial boerse-global.de
OHB shares dropped 8.9% after nine-month figures missed key estimates, though JPMorgan and NuWays kept positive ratings on the stock.
OHB's Margin Story Holds, but the Cash and Bottom-Line Numbers Are Still Playing Catch-Up Illustration mit AI erstellt.

OHB shareholders have a two-sided ledger to weigh after Thursday's nine-month update: an operating business that is clearly gaining traction, and a set of reported figures that left two of the analysts watching the stock underwhelmed on the metrics that matter most. The shares fell 8.9% in yesterday's session, a move that dpa-AFX linked to the quarterly disappointment rather than to any change in the confirmed full-year guidance.

At the heart of the debate is whether OHB can convert its improving operating profitability into convincing cash generation and a firmer result below the line. The confirmed outlook gives investors a concrete yardstick: group output of around EUR 1,400 Mio. for 2026 and an adjusted EBITDA margin of 10.5–11.0%.

Strong operating momentum, softer bottom line

The nine-month figures make the case for the bull camp. Total output reached EUR 946.5 Mio., an increase of 10%. Adjusted EBITDA climbed 23% to EUR 99.7 Mio., and adjusted EBIT rose 30% — both outpacing top-line growth and pointing to better operating leverage, provided the trend carries through the rest of the year.

The view under the line is less flattering. Profit for the period came in at EUR 19.137 Mio., down from EUR 24.384 Mio. a year earlier, a decline of 22%. Earnings per share eased to EUR 0.96. Rising adjusted earnings set against a falling net result leave a mixed picture that cautious investors will want resolved before they lean back in.

Should investors sell immediately? Or is it worth buying OHB SE?

JPMorgan flags a 7% miss, keeps its Overweight

David Perry of JPMorgan put the shortfall in adjusted operating profit against consensus at 7% on Thursday. Adjusted free cash flow also came in below expectations. Even so, Perry kept his Overweight rating and a EUR 300 price target, pairing a constructive valuation view with pointed criticism of the latest set of numbers.

NuWays struck a more upbeat tone in its update yesterday, highlighting the further margin improvement and leaving its Buy recommendation and EUR 340 target unchanged. The broker did trim its 2026 and 2027 estimates, citing somewhat weaker growth and higher one-off costs — a reminder that a positive long-term call can coexist with lower near-term earnings forecasts.

What would tip the balance

The optimistic case rests on OHB extending its operating improvement and delivering the confirmed margin band by year-end. Should that come alongside stronger cash inflows, the recent weakness could be read as a single reporting period's expectations problem rather than a deeper crack. A more convincing free cash flow would go a long way toward neutralizing the central criticism of Thursday's release.

OHB SE at a turning point? This analysis reveals what investors need to know now.

The risk scenario runs the other way: growth stays subdued, one-off costs linger, and cash conversion keeps lagging. Under those conditions, even an achieved margin target would carry less weight, particularly if the net result remains soft. Further estimate cuts would sharpen that risk.

For now, the decision comes down to how much credit investors extend in advance. The next hard test arrives with the publication of further earnings and cash flow figures — above all, whether OHB can tie its operating progress to healthier cash generation and a sturdier result below the line.

Ad

OHB SE Stock: New Analysis - 14 November

Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated OHB SE analysis...

Disclaimer...
en | DE0005936124 | OHBS | boerse | 70511666 |